
New Mexico Measles Outbreak Cost Reached $5.4 Million, Study Finds
Aug 04, 2026 03:23 am UTC| Health Governance
A 2025 measles outbreak in New Mexico cost nearly $5.4 million, highlighting the significant financial burden infectious disease outbreaks place on healthcare systems and public health agencies, according to a new study...

Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Aug 03, 2026 06:02 am UTC| Business Health
Novo Nordisk is showing signs of recovery after a difficult two-year stretch marked by profit warnings, leadership changes, and a sharp decline in its share price. The Danish pharmaceutical giant is gaining renewed...

AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
Aug 03, 2026 00:55 am UTC| Business Health
AstraZeneca Plc and Bristol Myers Squibb have reportedly held preliminary discussions about a potential merger that could create one of the worlds largest pharmaceutical companies, with a combined market value approaching...

3 clinical-grade skincare creams you really shouldn’t buy online
Jul 30, 2026 07:38 am UTC| Insights & Views Health
Your social media feed is full of people talking about the holy grail of skincare. Youve Googled, lurked on the Reddit forums and decided its time to try a clinical-grade product. But do you really need a prescription?...

GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Jul 29, 2026 04:11 am UTC| Business Health
GSK has announced a 1.9 billion ($2.52 billion) cost-savings initiative aimed at accelerating drug development and strengthening its long-term growth strategy as the British pharmaceutical giant prepares for the loss of...

AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
Jul 27, 2026 09:02 am UTC| Business Health
AstraZeneca (LON: AZN) reported stronger-than-expected second-quarter earnings on Monday, reaffirming its 2026 guidance as robust demand for its Oncology and Rare Disease portfolio continued to offset the impact of...

FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise
Jul 23, 2026 01:23 am UTC| Health Governance
The U.S. Food and Drug Administration (FDA) has launched an investigation into a new cyclospora outbreak after identifying 72 illnesses linked to an unknown source, adding to the growing number of infections reported...